| Financial Year |
March 31 2023 |
| Monetary Funds |
606,406,432.10 |
| Held-for-trading Financial Assets |
11,589,164.32 |
| Notes Receivable |
23,264,929.14 |
| Accounts Receivable |
121,622,440.03 |
| Advances to Suppliers |
465,765,738.07 |
| Other Receivables |
495,714,857.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
657,412,601.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,019,807.66 |
| Total Current Assets |
2,434,795,970.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
550,149,653.24 |
| Investment Properties |
166,159,177.18 |
| Fixed Assetes |
426,437,418.16 |
| Under-construction Projects |
29,351,314.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
318,847,598.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,740,012.01 |
| Deferred Income Tax Assets |
11,963,562.66 |
| Other Non-Current Assets |
59,125,333.76 |
| Sub-Total of Non-Current Assets |
1,821,667,711.55 |
| Total Assets |
4,256,463,682.01 |
| Short-Term Loans |
133,209,129.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
121,550,000.00 |
| Accounts Payable |
137,420,589.12 |
| Accounts Received In Advance |
7,788,847.95 |
| Employee Compensation Payable |
4,984,642.28 |
| Taxes Payable |
82,081,895.12 |
| Interest Payable |
-- |
| Dividend Payable |
15,386,135.32 |
| Other payables |
85,528,630.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
25,219,696.66 |
| Sub-Total of Current Liabilities |
791,126,014.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,675,819.19 |
| Deferred Income Tax Liabilities |
2,881,987.73 |
| Other Non-Current Liabilities |
128,466,666.25 |
| Sub-Total of Non-Current Liabilities |
153,024,473.17 |
| Total Liabilities |
944,150,487.87 |
| Paid-In Capital(Or Share Stock) |
468,144,464.00 |
| Capital Surplus |
999,789,116.50 |
| Surplus Reserve |
183,989,603.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,509,992,022.63 |
| Minority Stockholder's Interest |
182,342,291.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,129,970,902.77 |
| Owner's Equity（Stockholder's Equity） |
3,312,313,194.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,256,463,682.01 |
